BHC - Bausch Health Companies Inc.
NYSE
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Laval,
Canada
Type: Equity
BHC price evolution
BHC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $623 | $755 | $962 | |
| Short term investments | ||||
| Net receivables | $2094 | $2102 | $2048 | $1998 |
| Inventory | $1655 | $1612 | $1636 | $1544 |
| Total current assets | $5351 | $5211 | $5396 | $5596 |
| Long term investments | ||||
| Property, plant & equipment | $1789 | $1738 | $1713 | $1707 |
| Goodwill & intangible assets | $17030 | $17343 | $17639 | |
| Total noncurrent assets | $21284 | $21517 | $21754 | |
| Total investments | ||||
| Total assets | $26540 | $26495 | $26913 | $27350 |
| Current liabilities | ||||
| Accounts payable | $667 | $579 | $642 | $719 |
| Deferred revenue | ||||
| Short long term debt | $452 | $538 | $450 | |
| Total current liabilities | $4506 | $4369 | $4405 | $4302 |
| Long term debt | $21054 | $21208 | $21536 | $21938 |
| Total noncurrent liabilities | $22353 | $22682 | $23130 | |
| Total debt | $21660 | $22074 | $22388 | |
| Total liabilities | $27714 | $26722 | $27087 | $27432 |
| Shareholders' equity | ||||
| Retained earnings | -$9917 | -$9832 | -$9842 | -$9778 |
| Other shareholder equity | -$1947 | -$2007 | -$1917 | -$1881 |
| Total shareholder equity | -$1175 | -$1115 | -$1022 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $962 | $591 | $2119 | $1816 |
| Short term investments | ||||
| Net receivables | $1998 | $1790 | $1775 | $1577 |
| Inventory | $1544 | $1090 | $993 | $1094 |
| Total current assets | $5596 | $4247 | $5607 | $5342 |
| Long term investments | ||||
| Property, plant & equipment | $1707 | $1821 | $1598 | $1567 |
| Goodwill & intangible assets | $17639 | $17347 | $19405 | $21489 |
| Total noncurrent assets | $21754 | $21439 | $23595 | $25857 |
| Total investments | ||||
| Total assets | $27350 | $25686 | $29202 | $31199 |
| Current liabilities | ||||
| Accounts payable | $719 | $521 | $407 | $337 |
| Deferred revenue | ||||
| Short long term debt | $450 | $432 | ||
| Total current liabilities | $4302 | $3941 | $5198 | $4913 |
| Long term debt | $21938 | $20334 | $22654 | $23925 |
| Total noncurrent liabilities | $23130 | $21485 | $24038 | $25681 |
| Total debt | $22388 | $20766 | $22654 | $23925 |
| Total liabilities | $27432 | $26378 | $29236 | $30594 |
| Shareholders' equity | ||||
| Retained earnings | -$9778 | -$9186 | -$8961 | -$8013 |
| Other shareholder equity | -$1881 | -$2056 | -$1924 | -$2133 |
| Total shareholder equity | -$1022 | -$692 | -$106 | $535 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2510 | $2403 | $2153 | $2408 |
| Cost of revenue | $719 | $640 | $705 | |
| Gross Profit | $1814 | $1684 | $1513 | $1703 |
| Operating activities | ||||
| Research & development | $156 | $151 | $152 | |
| Selling, general & administrative | $832 | $794 | $766 | |
| Total operating expenses | $1285 | $1295 | $1232 | $1341 |
| Operating income | $389 | $281 | $362 | |
| Income from continuing operations | ||||
| EBIT | $409 | $299 | $364 | |
| Income tax expense | $71 | $49 | $8 | $40 |
| Interest expense | -$339 | $350 | $355 | $363 |
| Net income | ||||
| Net income | -$85 | $10 | -$64 | -$39 |
| Income (for common shares) | $10 | -$64 | -$39 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8757 | $8124 | $8434 | $8027 |
| Cost of revenue | $2559 | $2364 | $2394 | $2249 |
| Gross Profit | $6198 | $5760 | $6040 | $5778 |
| Operating activities | ||||
| Research & development | $604 | $529 | $465 | $452 |
| Selling, general & administrative | $2917 | $2625 | $2624 | $2367 |
| Total operating expenses | $5235 | $5306 | $5590 | $5102 |
| Operating income | $963 | $454 | $450 | $676 |
| Income from continuing operations | ||||
| EBIT | $957 | $1322 | $391 | $599 |
| Income tax expense | $221 | $83 | -$87 | -$375 |
| Interest expense | $1328 | $1464 | $1426 | $1534 |
| Net income | ||||
| Net income | -$592 | -$225 | -$948 | -$560 |
| Income (for common shares) | -$592 | -$225 | -$948 | -$560 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $10 | -$64 | -$39 | |
| Operating activities | ||||
| Depreciation | $318 | $320 | $329 | |
| Business acquisitions & disposals | $1 | $1 | -$3 | |
| Stock-based compensation | $36 | $33 | $29 | |
| Total cash flows from operations | $380 | $211 | $390 | |
| Investing activities | ||||
| Capital expenditures | -$79 | -$83 | -$144 | |
| Investments | -$1 | $3 | -$1 | |
| Total cash flows from investing | -$254 | -$79 | -$73 | -$148 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24 | |||
| Net borrowings | -$415 | -$319 | -$57 | |
| Total cash flows from financing | -$953 | -$424 | -$340 | -$79 |
| Effect of exchange rate | -$1 | -$9 | -$5 | $19 |
| Change in cash and equivalents | -$212 | -$132 | -$207 | $182 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$592 | -$225 | -$948 | -$560 |
| Operating activities | ||||
| Depreciation | $1264 | $1394 | $1552 | $1825 |
| Business acquisitions & disposals | -$1885 | -$40 | $669 | $21 |
| Stock-based compensation | $132 | $126 | $128 | $105 |
| Total cash flows from operations | $1032 | -$728 | $1426 | $1111 |
| Investing activities | ||||
| Capital expenditures | -$272 | -$268 | -$283 | -$309 |
| Investments | -$1 | $5 | -$4 | $4 |
| Total cash flows from investing | -$2145 | -$303 | $409 | -$261 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24 | -$31 | -$52 | -$30 |
| Net borrowings | $1545 | -$1081 | -$1388 | -$2226 |
| Total cash flows from financing | $1475 | -$474 | -$1513 | -$2294 |
| Effect of exchange rate | $9 | -$23 | -$19 | $16 |
| Change in cash and equivalents | $371 | -$1528 | $303 | -$1428 |
News
Fundamentals
| Market cap | $2.92B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 367.70M |
| Revenue | $9.47B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$178.00M |
| Revenue Q/Q | 12.15% |
| Revenue Y/Y | 10.91% |
| P/E ratio | -16.42 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.31 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.48 |
|---|---|
| ROA | -0.66% |
| ROE | N/A |
| Debt/Equity | -26.84 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.19 |
| Quick ratio | 0.82 |